Search Results - Sarah L Larsen
- Showing 1 - 1 results of 1
-
1
SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatment. by Sarah L Larsen, Anne-Vibeke Laenkholm, Anne Katrine Duun-Henriksen, Martin Bak, Anne E Lykkesfeldt, Tove Kirkegaard
Published in PLoS ONE (2015-01-01)Get full text
Article